Overcoming Resistance to EGFR Neutralization by Combination of Monoclonal Antibodies and Novel Cancer Drugs
Clinical trial NCT06863818 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06863818
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2022-10-10
- Primary completion
- 2024-03-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.